Xingang Li | harmacology | Best Research Article Award

Prof. Xingang Li | pharmacology | Best Research Article Award 

Prof. Xingang Li, Department of Pharmacy, Beijing Friendship Hospital, China

Prof. Xingang Li is the Deputy Director of the Pharmacy Department at Beijing Friendship Hospital, China, where he also serves as a Chief Pharmacist, Professor, and Ph.D. Supervisor. An expert in quantitative pharmacology and genetic pharmacology, Prof. Li has published over 50 articles in top-tier journals, with more than 1000 citations and an H-index of 20. He is an External Expert at the National Center for Drug Evaluation, a member of multiple prestigious pharmacological committees, and a reviewer for leading journals such as Biomaterials and Clin Transl Med. His research focuses on personalized medicine, drug delivery systems, and epigenetic influences on pharmacodynamics.

Profile:

Orcid Profile

🏥 Current Positions:

Prof. Li Xingang serves as the Deputy Director of the Pharmacy Department at Beijing Friendship Hospital, where he is also the Chief Pharmacist. As a Professor and Ph.D. Supervisor, he is instrumental in nurturing future generations of pharmacists and researchers. His leadership role involves overseeing advanced pharmacological practices, mentoring young scientists, and ensuring cutting-edge drug evaluation and management systems. With a strong emphasis on precision medicine, Prof. Li combines clinical expertise and research excellence to address pressing healthcare challenges.

📚 Academic Background:

Prof. Li has an extensive academic background, which underpins his outstanding contributions to quantitative pharmacology and genetic pharmacology. His role as an External Expert at the National Center for Drug Evaluation and Review Expert for the Beijing Science and Technology Plan Project showcases his authority in the field. His memberships in prestigious committees, such as the Quantitative Pharmacology Committee of the Chinese Pharmacological Society and the Epigenetics Committee, reflect his deep commitment to advancing pharmaceutical sciences.

🧪 Research Interests and Achievements:

Quantitative Pharmacology: Prof. Li has a keen interest in developing predictive models to optimize drug efficacy and safety, leveraging mathematical frameworks to personalize treatment.

Genetic Pharmacology: His research focuses on exploring genetic factors that influence drug metabolism and efficacy, aiming to enhance personalized medicine approaches.

Prof. Li has successfully led over ten major projects, including initiatives funded by the Ministry of Science and Technology, the National Natural Science Foundation, and the Beijing Science and Technology Plan. These projects address critical areas like drug delivery systems, personalized pharmacotherapy, and genetic determinants of drug response.

🖋️ Publication Achievements:

Prof. Li’s academic rigor is evident in his extensive publication record, with over 50 articles in Q1 journals such as Nano Letters, Acta Pharmacologica Sinica, and Phytomedicine. His works have been cited more than 1000 times, and he holds an impressive H-index of 20, reflecting his impact on the scientific community. His publications explore innovative drug delivery systems, genetic biomarkers, and clinical pharmacokinetics, contributing significantly to global pharmacological advancements.

🏆 Scholarships and Awards:

Prof. Li has received numerous accolades for his contributions:

  • Servier Young Hospital Pharmacy Award, China Pharmaceutical Society
  • Outstanding Pharmacist Award, Beijing Pharmaceutical Society
  • Recognized for Outstanding Papers and groundbreaking research, reflecting his excellence in clinical pharmacy and translational research.

🧑‍🔬 Professional Associations and Editorial Roles:

Prof. Li is actively involved in professional organizations, including the Chinese Pharmacological Society and the China Pharmaceutical Education Association. He serves as an Editorial Board Member for journals such as China Hospital Pharmacy Evaluation and Analysis and Chinese Pharmacy, ensuring the dissemination of high-quality research.

As a Reviewer for prestigious journals like Biomaterials and Clin Transl Med, he evaluates cutting-edge studies in pharmacology, bioinformatics, and materials science, further contributing to his field’s knowledge base.

💻 Bioinformatics and Laboratory Experience:

Prof. Li integrates bioinformatics tools into his research to analyze complex datasets and identify genetic markers associated with drug response. His laboratory is equipped with advanced technologies for pharmacokinetic modeling, epigenetic profiling, and drug formulation analysis, enabling groundbreaking discoveries.

🎓 Training, Workshops, and Oral Presentations:

Prof. Li regularly participates in international conferences, presenting his research findings and engaging with global experts. His oral presentations at prestigious forums highlight advancements in therapeutic drug monitoring (TDM), anesthesiology pharmacy, and intravenous preparation management, solidifying his reputation as a thought leader.

✅ Tasks Completed as a Researcher:

Prof. Li has successfully completed tasks ranging from designing clinical trials to publishing high-impact research. His ability to translate laboratory findings into practical solutions for patient care exemplifies his commitment to improving healthcare outcomes.

🌟 Success Factors and Key Contributions:

Prof. Li’s success stems from his:

  • Collaborative approach in multidisciplinary projects
  • Innovative methodologies in drug evaluation and genetic research
  • Dedication to mentoring young professionals and fostering academic growth

🔬 Ongoing Research Projects:

His current projects delve into:

  • Advanced drug delivery systems to enhance treatment efficacy
  • Epigenetic influences on pharmacodynamics
  • Personalized medicine approaches using genetic profiling

🔍 Conclusion:

Prof. Li Xingang is a distinguished leader in the field of pharmacology, whose contributions span clinical excellence, innovative research, and impactful publications. His work in quantitative and genetic pharmacology, combined with his dedication to mentoring and professional engagement, sets him apart as a visionary in healthcare. His achievements and ongoing endeavors continue to shape the future of precision medicine and pharmacological sciences.

Top Notable Publications:

1. Immune-Related Colitis Induced by Camrelizumab: A Case Report

Authors: Xingang Li

Journal: Journal of Inflammation Research

Year: 2023

2. Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients

Authors: Xingang Li

Journal: European Journal of Hospital Pharmacy: Science and Practice-

Year: 2023

3. Association of Alcohol Drinking and Helicobacter pylori Infection: A Meta-analysis

Authors: Xingang Li

Journal: Journal of Clinical Gastroenterology

Year: 2023

4. Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients

Authors: Xingang Li

Journal: European Journal of Hospital Pharmacy: Science and Practice

Year: 2022

5. Association between GNAQ Gene DNA Methylation and Vascular Recurrence in Patients with Acute Ischemic Stroke or Transient Ischemic Attack

Authors: Xingang Li

Journal: Cerebrovascular Diseases (Basel, Switzerland)

Year: 2022

6. Impact of Azithromycin on Forsythiaside Pharmacokinetics in Rats: A Population Modeling Method

Authors: Xingang Li

Journal: Current Medical Science

Year: 2022

7. Docetaxel population pharmacokinetic modelling and simulation in Chinese cancer patients

Authors: Xingang Li

Journal: Annals of Translational Medicine

Year: 2022

8. Development of a multivariable clinical prediction model for liposomal doxorubicin-induced cardiotoxicity in adult breast cancer patients: A retrospective multicenter study

Authors: Xingang Li

Journal: Annals of Translational Medicine

Year: 2022

9. Population pharmacokinetics of methotrexate in pediatric patients with acute lymphoblastic leukemia and malignant lymphoma

Authors: Xingang Li

Journal: Xenobiotica

Year: 2022

10. The clinical population pharmacokinetics, metabolomics, and therapeutic analysis of alkaloids from Alstonia scholaris leaves in acute bronchitis patients

Authors: Xingang Li

Journal: Phytomedicine

Year: 2022

Cancan Zhou | Hepatic toxicology | Best Research Award

Prof. Cancan Zhou | Hepatic toxicology  | Best Research Award

Prof. Cancan Zhou, Shanghai Tenth People’s Hospital, China

Prof. Cancan Zhou is a distinguished researcher at the Department of Pharmacy, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, China. He is an active member of the Shanghai Pharmacological Society Clinical Drug Evaluation Committee and the Shanghai Hospital Association Clinical Pharmaceutical Management Committee. Prof. Zhou has led a youth project under the National Natural Science Foundation of China, funded by the Shanghai Sailing Program, and has authored over 10 SCI-indexed papers as the first or corresponding author. Her expertise focuses on hepatic toxicology, drug safety, and advanced pharmacological research.

Profile:

📘 EARLY ACADEMIC PURSUITS:

The Department of Pharmacy at Shanghai Tenth People’s Hospital, affiliated with Tongji University School of Medicine, Shanghai, China, serves as a cornerstone for advanced clinical pharmaceutical education and research. With a strong emphasis on evidence-based practices and innovation, the academic foundation was laid through rigorous training in drug evaluation, pharmaceutical management, and patient-centric care. This foundation has enabled significant advancements in the field of clinical pharmacy.

💼 PROFESSIONAL ENDEAVORS:

As a Member of the Shanghai Pharmacological Society Clinical Drug Evaluation Committee and the Shanghai Hospital Association Clinical Pharmaceutical Management Committee, the individual plays a pivotal role in shaping clinical pharmaceutical policies and practices. These roles underscore a dedication to improving healthcare systems, advancing drug evaluation protocols, and ensuring the highest standards of pharmaceutical care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON Hepatic toxicology :

A highlight of this career is the successful leadership of a youth project under the National Natural Science Foundation of China, supported by the prestigious Shanghai Sailing Program. The research primarily focuses on:

  • Clinical Drug Evaluation 🩺
  • Innovative Pharmaceutical Management Strategies 📈
  • Advancing Patient-Centered Therapies 🤝

This work has had a transformative effect on improving drug safety, efficacy, and accessibility in clinical settings.

🌟 IMPACT AND INFLUENCE:

With more than 10 SCI-indexed publications as the first or corresponding author, the individual’s research contributions have significantly influenced both academic discussions and practical applications in the pharmaceutical sciences. These publications have enhanced the understanding of clinical drug evaluation processes and established benchmarks for excellence in research methodologies.

📖 ACADEMIC CITES:

The widespread citation of these publications reflects their impact on the global scientific community. The work has inspired new research, informed clinical guidelines, and contributed to the development of innovative therapeutic strategies. These achievements highlight the individual’s reputation as a thought leader in pharmaceutical sciences.

🔮 LEGACY AND FUTURE CONTRIBUTIONS:

This career reflects a legacy of excellence, blending cutting-edge research with impactful professional service. Moving forward, the focus is expected to center on:

  • Integrating Artificial Intelligence into Drug Evaluation 🤖
  • Developing Sustainable Healthcare Practices 🌱
  • Expanding International Collaborations in Clinical Research 🌍

These contributions aim to enhance healthcare outcomes, streamline pharmaceutical processes, and pave the way for next-generation drug development and management.

💡 OTHER IMPORTANT TOPICS:

🏆 LEADERSHIP IN CLINICAL PHARMACEUTICAL COMMITTEES

Active participation in key committees showcases exemplary leadership and the ability to influence policy decisions that shape the future of clinical pharmacy in Shanghai and beyond.

📈 SUCCESS IN YOUTH PROJECTS

The youth project, supported by competitive funding, highlights the individual’s capacity to lead high-impact research. This success demonstrates both academic merit and the ability to deliver results in fast-evolving scientific domains.

👨‍🏫 MENTORSHIP AND EDUCATION

As part of Tongji University School of Medicine, the individual likely contributes to training the next generation of clinical pharmacists, fostering innovation, and promoting ethical and evidence-based practices.

🌍 VISION FOR GLOBAL PHARMACEUTICAL INTEGRATION

Future aspirations include strengthening cross-border collaborations to harmonize pharmaceutical standards, improve global drug accessibility, and contribute to sustainable healthcare practices worldwide.

✨ CONCLUSION:

The professional journey outlined reflects a remarkable blend of academic excellence, impactful research, and leadership in clinical pharmacy. With a clear vision for future contributions, this profile is set to continue driving innovation, improving patient care, and leaving a lasting legacy in pharmaceutical sciences.

TOP NOTABLE PUBLICATIONS:

STING Signaling Contributes to Methotrexate-Induced Liver Injury by Regulating Ferroptosis in Mice

Authors: Wang, H.-F.; He, Y.-Q.; Ke, Z.; Zhou, C.-C.; Xu, J.-S.

Journal: Ecotoxicology and Environmental Safety

Year: 2024

Natural Products for the Treatment of Chemotherapy-Related Cognitive Impairment and Prospects of Nose-to-Brain Drug Delivery

Authors: He, Y.-Q.; Zhou, C.-C.; Jiang, S.-G.; Tao, X.; Chen, W.-S.

Journal: Frontiers in Pharmacology

Year: 2024

Ursodeoxycholic Acid Alleviates Sepsis-Induced Lung Injury by Blocking PANoptosis via STING Pathway

Authors: He, Y.-Q.; Deng, J.-L.; Zhou, C.-C.; Tao, X.; Chen, W.-S.

Journal: International Immunopharmacology

Year: 2023

Long Survival in a Pancreatic Carcinoma Patient with Multi-Organ Toxicities After Sintilimab Treatment: A Case Report

Authors: Ni, C.-X.; Zhao, Y.; Qian, H.; Li, D.-J.; Xu, Q.

Journal: Frontiers in Pharmacology

Year: 2023

Clinical Features of Omicron SARS-CoV-2 Variants Infection Associated with Co-Infection and ICU-Acquired Infection in ICU Patients

Authors: Li, D.-J.; Zhou, C.-C.; Huang, F.; Shen, F.-M.; Li, Y.-C.

Journal: Frontiers in Public Health

Year: 2023

Zinc Supplementation Ameliorates Sorafenib-Induced Cognitive Impairment Through ROS/JNK Signaling Pathway

Authors: Zhou, C.-C.; He, Y.-Q.; Qiu, Y.-S.; Shen, F.-M.; Li, D.-J.

Journal: Biological Trace Element Research

Year: 2023

Exerkine Fibronectin Type-III Domain-Containing Protein 5/Irisin-Enriched Extracellular Vesicles Delay Vascular Ageing by Increasing SIRT6 Stability

Authors: Chi, C.; Fu, H.; Li, Y.-H.; Li, D.-J.; Wang, P.

Journal: European Heart Journal

Year: 2022

Activating α7nAChR Ameliorates Abdominal Aortic Aneurysm Through Inhibiting Pyroptosis Mediated by NLRP3 Inflammasome

Authors: Fu, H.; Shen, Q.-R.; Zhao, Y.; Liang, G.; Shen, F.-M.

Journal: Acta Pharmacologica Sinica

Year: 2022

Lead Exposure in Developmental Ages Promotes Aβ Accumulation by Disturbing Aβ Transportation in Blood-Cerebrospinal Fluid Barrier/Blood–Brain Barriers and Impairing Aβ Clearance in the Liver

Authors: Zhou, C.-C.; Wang, X.-J.; Li, Z.-C.; Shen, F.-M.; Li, D.-J.

Journal: Biological Trace Element Research

Year: 2022

Abdominal Aortic Aneurysm: Pathological Mechanism and Animal Model

Authors: Fu, H.; Zhou, C.; Li, D.; Shen, F.

Journal: Acta Academiae Medicinae Sinicae

Year: 2022